University of Glasgow at ObesityWeek 2026
Nov 14–17, 2026 National Harbor, MD ~4.4k attendees Website
University of Glasgow brings 2 presentations to ObesityWeek 2026 in National Harbor. Its sessions span obesity drug trials and the links between body fat and mental health. One evaluates enicepatide in phase 3 studies of people with overweight or obesity with or without type 2 diabetes, and another compares central and general obesity in depression and anxiety using UK Biobank.
| Organization | ObesityWeek 2026 Attendance |
|---|---|
University of Glasgow Glasgow, UK | |
Public research university in Glasgow, Scotland, with a medical school. | Poster Sat Nov 14 7:30pm–8:30pm Two Phase 3 Studies Evaluating Enicepatide in People With Overweight/Obesity With or Without T2D Neuroscience of appetite and eatingNutrition, diet and food Poster Mon Nov 16 2:30pm–3:30pm Central Versus General Obesity in Depression and Anxiety: A Cross-Sectional Analysis in UK Biobank Clinical obesity care and professional practice |
Find decision makers at University of Glasgow
Tell us what you sell and we’ll find the people at University of Glasgow most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by The Obesity Society (TOS), ObesityWeek® or the American Society for Metabolic and Bariatric Surgery (ASMBS). Submit a correction